The Medtech & Pharma Platform Association (MPP) wishes to respectfully draw attention to a series of persistent challenges that continue to hinder the effective and proportionate functioning of the European Unions regulatory framework governing medical devices and in vitro diagnostics.
MPP
Medtech & Pharma Platform (MPP)
Industry association · Switzerland · EU Transparency Register 234427831877-10
3
positions filed
in the 326 files tracked
3
legislative files
of 326 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #568 by legislative files engaged — a count of participation, not a measure of influence.
0.8
declared lobbying FTE
self-declared
€200K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2018
in the register since
- Register category
- Trade and business associations
- Registered as
- Medtech & Pharma Platform Association (MPP)
- Head office
- Basel, Switzerland
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Medtech in PolicySpeak: request access →
Work at Medtech & Pharma Platform (MPP)? so we know who speaks for it.
Their record over time
Medtech & Pharma Platform (MPP) filed 3 positions between 11 Jun 2025 and 23 Jan 2026, across 3 of the 326 legislative files tracked here, attaching a full position paper 1 time.
2025 · 2 filed2026 · 1 filed
What they argued
The Medtech & Pharma Platform Association (MPP) brings together companies from the pharmaceutical, MedTech, Diagnostics, and Tech sectors to advance combined products, i.e. solutions that integrate drugs, devices, diagnostics, and digital technologies for medical purposes.
The Medtech & Pharma Platform Association (MPP) welcomes the proposed EU Implementing Regulation establishing harmonised quality management and procedural requirements for conformity assessment activities performed by notified bodies. We consider the introduction of requirements for reliable quotations, predictable timelines, and transparent monitoring of both timelines and costs to be a positive step.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- MedTech Europe · 3 files in common
- EURAMET e.V. · 3 files in common
- Cruelty Free Europe · 3 files in common
- Pharma Deutschland e.V. · 3 files in common
- SOMA Genomics · 3 files in common
Showing 5 of 66.
Is this your organization?
Everything on this page comes from Medtech & Pharma Platform (MPP)’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.